DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more



Prescribing patterns of lithium or lithium+valproate in manic or mixed episodes: a naturalistic study.

Author(s): Muti M(1), Del Grande C, Musetti L, Marazziti D, Pergentini I, Corsi M, Turri M, Umberto Corsini G, Dell'Osso L.

Affiliation(s): Author information: (1)Departments of aTranslational Research and New Technologies in Medicine and Surgery bClinical and Experimental Medicine, University of Pisa, Pisa, Italy.

Publication date & source: 2013, Int Clin Psychopharmacol. , 28(6):305-11

The present study aimed to identify the prescribing patterns of lithium or of lithium+valproate in 75 bipolar I outpatients in a manic or a mixed phase within a naturalistic setting. The differences between the two treatments and the correlation between serum lithium levels and response were also examined. The results showed that patients with lithium levels of 0.60 mEq/l or more had higher remission rates and greater symptom reduction than the other patients. Patients on lithium and valproate showed greater improvement in mixed, anxiety, and psychotic symptoms than those on lithium only, as assessed by the Clinical Global Impression-Bipolar version scale scores. Finally, our findings suggest that a range of lithium levels between 0.40 and 0.60 mEq/l, albeit below the therapeutic range, seems sufficient to maintain a good effect when lithium is coadministered with valproate.

Page last updated: 2014-11-30

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017